Back to All Events

Johnson & Johnson Innovation Webinar

To register for this event, please click here.

Do you want to propel your start-up or innovative project to new heights? A collaboration or partnership with a large medtech or pharma company might be a valuable opportunity to explore. Depending on your needs, it could provide access to funding, resources, expertise, and networks which are otherwise might otherwise remain out of reach. In turn this could help to speed up development and enhance the overall probability of regulatory approval and market success for a new healthcare intervention, thus de-risking the overall development.

To a start-up company , the process of building a collaboration with a large healthcare company might seem daunting and the criteria used for assessing potential deals unclear. During this Johnson & Johnson Innovation – JLABS program we will demystify what due diligence entails, what the pitfalls are and how you might set yourself up for success.

Previous
Previous
27 June

SPARK cohort meeting

Next
Next
24 July

SPARK Studio: Life Science Pitch Strategies and VC Due Diligence